Humana (HUM) has been experiencing a mix of gains and losses according to various recent events in the market. Options traders seem to be aware of some information about the stocks that are not yet known to the public. While some investment firms like Sanders Capital LLC and SageView Advisory Group LLC are investing heavily into Humana, others such as US Bancorp DE are selling their shares. The stock recently faced a disappointing increase in Medicare Advantage Rate, resulting in its sliding. However, it managed to beat the Q3 earnings and revenue estimates. This got it an average recommendation to hold from analysts. Despite the recent mixed reactions in the market, Wall Street holds a bullish view, making it worth investing in. However, the shares tumbled on concerns about heightened medical utilization. Humana is warning of a hit to its 2025 profit which resulted in its share sinking. Elevated Medicare costs and Q4 losses have also negatively impacted its 2023 performance.
Humana HUM News Analytics from Wed, 15 Nov 2023 14:00:53 GMT to Fri, 31 May 2024 01:09:42 GMT -
Rating -3
- Innovation 2
- Information 6
- Rumor -5
